Breakthrough Drug Cuts Alzheimer’s Risk by 50% in High-Risk Patients

A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that removing amyloid from the brain may help prevent symptoms, highlighting the need for further confirmatory studies. An experimental drug may significantly reduce the risk of Alzheimer’s-related dementia in individuals genetically predisposed to develop the disease in their 30s, 40s, or 50s, […] Read More